目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global celiac diseases drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global celiac diseases drugs market 2017 - 2021 ($ million)
4.2 Therapy Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
4.3 Route of Administration Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy
6.1 Market segments
Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
6.2 Comparison by Therapy
Exhibit 32: Chart on Comparison by Therapy
Exhibit 33: Data Table on Comparison by Therapy
6.3 First line treatment - Market size and forecast 2022-2027
Exhibit 34: Chart on First line treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on First line treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on First line treatment - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on First line treatment - Year-over-year growth 2022-2027 (%)
6.4 Second-line treatment - Market size and forecast 2022-2027
Exhibit 38: Chart on Second-line treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Second-line treatment - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Second-line treatment - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Second-line treatment - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Therapy
Exhibit 42: Market opportunity by Therapy ($ million)
Exhibit 43: Data Table on Market opportunity by Therapy ($ million)

7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 44: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 45: Data Table on Route of Administration - Market share 2022-2027 (%)
7.2 Comparison by Route of Administration
Exhibit 46: Chart on Comparison by Route of Administration
Exhibit 47: Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2022-2027
Exhibit 48: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Oral - Year-over-year growth 2022-2027 (%)
7.4 Parenteral - Market size and forecast 2022-2027
Exhibit 52: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Route of Administration
Exhibit 56: Market opportunity by Route of Administration ($ million)
Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Adaptive Biotechnologies Corp.
Exhibit 107: Adaptive Biotechnologies Corp. - Overview
Exhibit 108: Adaptive Biotechnologies Corp. - Product / Service
Exhibit 109: Adaptive Biotechnologies Corp. - Key offerings
12.4 Almirall SA
Exhibit 110: Almirall SA - Overview
Exhibit 111: Almirall SA - Product / Service
Exhibit 112: Almirall SA - Key news
Exhibit 113: Almirall SA - Key offerings
12.5 Amgen Inc.
Exhibit 114: Amgen Inc. - Overview
Exhibit 115: Amgen Inc. - Product / Service
Exhibit 116: Amgen Inc. - Key offerings
12.6 AMYRA Biotech AG
Exhibit 117: AMYRA Biotech AG - Overview
Exhibit 118: AMYRA Biotech AG - Product / Service
Exhibit 119: AMYRA Biotech AG - Key offerings
12.7 BioLineRx Ltd.
Exhibit 120: BioLineRx Ltd. - Overview
Exhibit 121: BioLineRx Ltd. - Product / Service
Exhibit 122: BioLineRx Ltd. - Key offerings
12.8 Bristol Myers Squibb Co.
Exhibit 123: Bristol Myers Squibb Co. - Overview
Exhibit 124: Bristol Myers Squibb Co. - Product / Service
Exhibit 125: Bristol Myers Squibb Co. - Key news
Exhibit 126: Bristol Myers Squibb Co. - Key offerings
12.9 Calypso Biotech BV
Exhibit 127: Calypso Biotech BV - Overview
Exhibit 128: Calypso Biotech BV - Product / Service
Exhibit 129: Calypso Biotech BV - Key offerings
12.10 GlaxoSmithKline Plc
Exhibit 130: GlaxoSmithKline Plc - Overview
Exhibit 131: GlaxoSmithKline Plc - Business segments
Exhibit 132: GlaxoSmithKline Plc - Key news
Exhibit 133: GlaxoSmithKline Plc - Key offerings
Exhibit 134: GlaxoSmithKline Plc - Segment focus
12.11 Glenmark Pharmaceuticals Ltd.
Exhibit 135: Glenmark Pharmaceuticals Ltd. - Overview
Exhibit 136: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibit 137: Glenmark Pharmaceuticals Ltd. - Key offerings
12.12 ImmunogenX Inc.
Exhibit 138: ImmunogenX Inc. - Overview
Exhibit 139: ImmunogenX Inc. - Product / Service
Exhibit 140: ImmunogenX Inc. - Key offerings
12.13 Johnson and Johnson
Exhibit 141: Johnson and Johnson - Overview
Exhibit 142: Johnson and Johnson - Business segments
Exhibit 143: Johnson and Johnson - Key news
Exhibit 144: Johnson and Johnson - Key offerings
Exhibit 145: Johnson and Johnson - Segment focus
12.14 Precigen Inc.
Exhibit 146: Precigen Inc. - Overview
Exhibit 147: Precigen Inc. - Business segments
Exhibit 148: Precigen Inc. - Key offerings
Exhibit 149: Precigen Inc. - Segment focus
12.15 Sanofi
Exhibit 150: Sanofi - Overview
Exhibit 151: Sanofi - Business segments
Exhibit 152: Sanofi - Key news
Exhibit 153: Sanofi - Key offerings
Exhibit 154: Sanofi - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 155: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 156: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 163: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 164: Inclusions checklist
Exhibit 165: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 166: Currency conversion rates for US$
13.4 Research methodology
Exhibit 167: Research methodology
Exhibit 168: Validation techniques employed for market sizing
Exhibit 169: Information sources
13.5 List of abbreviations
Exhibit 170: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global celiac diseases drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on First line treatment - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on First line treatment - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on First line treatment - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on First line treatment - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Second-line treatment - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Second-line treatment - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Second-line treatment - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Second-line treatment - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Therapy ($ million)
Exhibits43: Data Table on Market opportunity by Therapy ($ million)
Exhibits44: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits45: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Route of Administration
Exhibits47: Data Table on Comparison by Route of Administration
Exhibits48: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Route of Administration ($ million)
Exhibits57: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Adaptive Biotechnologies Corp. - Overview
Exhibits108: Adaptive Biotechnologies Corp. - Product / Service
Exhibits109: Adaptive Biotechnologies Corp. - Key offerings
Exhibits110: Almirall SA - Overview
Exhibits111: Almirall SA - Product / Service
Exhibits112: Almirall SA - Key news
Exhibits113: Almirall SA - Key offerings
Exhibits114: Amgen Inc. - Overview
Exhibits115: Amgen Inc. - Product / Service
Exhibits116: Amgen Inc. - Key offerings
Exhibits117: AMYRA Biotech AG - Overview
Exhibits118: AMYRA Biotech AG - Product / Service
Exhibits119: AMYRA Biotech AG - Key offerings
Exhibits120: BioLineRx Ltd. - Overview
Exhibits121: BioLineRx Ltd. - Product / Service
Exhibits122: BioLineRx Ltd. - Key offerings
Exhibits123: Bristol Myers Squibb Co. - Overview
Exhibits124: Bristol Myers Squibb Co. - Product / Service
Exhibits125: Bristol Myers Squibb Co. - Key news
Exhibits126: Bristol Myers Squibb Co. - Key offerings
Exhibits127: Calypso Biotech BV - Overview
Exhibits128: Calypso Biotech BV - Product / Service
Exhibits129: Calypso Biotech BV - Key offerings
Exhibits130: GlaxoSmithKline Plc - Overview
Exhibits131: GlaxoSmithKline Plc - Business segments
Exhibits132: GlaxoSmithKline Plc - Key news
Exhibits133: GlaxoSmithKline Plc - Key offerings
Exhibits134: GlaxoSmithKline Plc - Segment focus
Exhibits135: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits136: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits137: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits138: ImmunogenX Inc. - Overview
Exhibits139: ImmunogenX Inc. - Product / Service
Exhibits140: ImmunogenX Inc. - Key offerings
Exhibits141: Johnson and Johnson - Overview
Exhibits142: Johnson and Johnson - Business segments
Exhibits143: Johnson and Johnson - Key news
Exhibits144: Johnson and Johnson - Key offerings
Exhibits145: Johnson and Johnson - Segment focus
Exhibits146: Precigen Inc. - Overview
Exhibits147: Precigen Inc. - Business segments
Exhibits148: Precigen Inc. - Key offerings
Exhibits149: Precigen Inc. - Segment focus
Exhibits150: Sanofi - Overview
Exhibits151: Sanofi - Business segments
Exhibits152: Sanofi - Key news
Exhibits153: Sanofi - Key offerings
Exhibits154: Sanofi - Segment focus
Exhibits155: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits156: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits157: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits158: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits159: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits160: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits161: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits162: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits163: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits164: Inclusions checklist
Exhibits165: Exclusions checklist
Exhibits166: Currency conversion rates for US$
Exhibits167: Research methodology
Exhibits168: Validation techniques employed for market sizing
Exhibits169: Information sources
Exhibits170: List of abbreviations